Summer EBT ‘SUN Bucks' going out this month
(WKBN) – Ohio's Sun Bucks program will be distributed through June.
The Summer Electronic Benefit Transfer Program for Children, also known as Summer EBT or SUN Bucks, is a federal program that provides assistance to eligible families with school-aged children while those schools are closed for the summer.
SUN Bucks is a one-time benefit of $120 per eligible child. The benefit will be distributed in batches through June.
Those receiving SNAP and Medicaid are automatically enrolled and will be loaded on the One Direction Card. New recipients will receive a benefit card by mail.
Like SNAP, the extra money can be used to buy goods at grocery stores, farmers markets, and other authorized retailers.
Last year, $144 million was given out in extra food assistance to over 1.2 million Ohio children through the SUN Bucks program.
Families not automatically eligible can learn more about the application process online.
Research shows that during a slowing economy, $1 billion in new SNAP benefits would lead to an increase of $1.54 billion in Gross Domestic Product (GDP), 54% above and beyond the new benefits.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
IOVA FRAUD ALERT: Iovance Biotherapeutics Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
an hour ago
- Business Upturn
FTRE FRAUD ALERT: Fortrea Holdings Inc. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by August 1 Legal Deadline (NASDAQ:FTRE)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting Investors have until August 1, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Fortrea securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Deslande v. Fortrea Holdings Inc., et al. , No. 1:25-cv-04630. Why was Fortrea Sued for Securities Fraud? Fortrea is a global contract research organization that provides biopharmaceutical product and medical device development solutions. In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ('Labcorp'). In connection with the spin-off, Fortrea entered into several transition services agreements (the 'TSAs'), pursuant to which it agreed to pay Labcorp for certain transitional services over a set period. As alleged, Fortrea discussed the significant cost savings and margin improvements that would result from exiting the TSAs. In truth, Fortrea overstated the cost savings and margin improvement it would achieve by exiting the TSAs, as well as the amount of revenue it would generate from pre-spin projects. The Stock Declines as the Truth is Revealed On September 25, 2024, investment bank Jefferies published a report stating that the cost savings Fortrea would achieve from exiting the TSAs were '[n]ot as [m]aterial as [o]ne [m]ight [t]hink.' On this news, the price of Fortrea stock declined $2.73 per share, or over 12%, from a closing price of $22.21 per share on September 24, 2024, to $19.48 per share on September 25, 2024. Then, on March 3, 2025, Fortrea announced disappointing Q4 and full year 2024 financial results, revealing that the company's pre-spin projects 'have less revenue and less profitability than expected for 2025' and that 'post-spin work is not coming on fast enough to offset the pre-spin contract economics.' On this news, the price of Fortrea stock declined $3.47 per share, or over 25%, from a closing price of $13.85 per share on February 28, 2025, to $10.38 per share on March 3, 2025, the next trading day. Click here if you suffered losses: What Can You Do? If you invested in Fortrea you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Miami Herald
4 hours ago
- Miami Herald
Donald Trump's SNAP Benefit Cut Plans Suffer Blow
A plan by Republicans to shift a portion of federal food stamp costs to state governments suffered a major setback after the Senate parliamentarian found it would violate chamber rules. The blocked provision was an attempt to reduce federal spending on the Supplemental Nutrition Assistance Program (SNAP), affecting more than 40 million low-income Americans who rely on food aid. The shift would have transferred major SNAP costs to the states, requiring them to pay at least 5 percent—and potentially more—of benefit costs, which analysts warned could result in significant cuts to nutrition support. The parliamentarian's decision places additional pressure on the bill's champions to find alternative means to fund tax cuts without imperiling food assistance, Medicaid, or other federal support programs. The provision, a cornerstone of Republican efforts to offset the costs of President Donald Trump's multitrillion-dollar tax and spending legislation, has been ruled inadmissible under Senate rules, sending GOP leaders scrambling to revise the mega bill. The ruling, issued by Senate parliamentarian Elizabeth MacDonough, came as the package prepared for a vote. While her opinions are advisory, they are rarely ignored in lawmaking practice. Republican lawmakers are now searching for new savings as they continue to advance Trump's legislative priorities despite the setback. MacDonough declared the SNAP cost-sharing plan noncompliant with the chamber's budget reconciliation rules, specifically the Byrd Rule, which bars certain policy measures from being attached to budget bills. The proposal would have shifted billions of dollars in SNAP costs from the federal government to the states, creating a new fiscal obligation for state governments and threatening coverage for millions. House Passes Bill with GOP SNAP Cuts The House passed the broader tax and spending package along party lines in May 2025, including a provision to require states to fund at least 5 percent of SNAP benefits and more for high error rates. The House-passed measure's SNAP provision was projected to save about $128 billion. Republican leaders had hoped these savings would help offset the bill's $4.5 trillion in tax cuts and new spending. Other Key Provisions Beyond SNAP, the package includes an extension and expansion of individual and business tax cuts, new work requirements for Medicaid recipients, cuts to federal health and nutrition programs, increased military and border security funding, and the elimination of taxes on tips for service workers. GOP Paths Forward Republican leaders, including Senate Agriculture Committee Chair John Boozman of Arkansas, said they were exploring options to keep the legislation on track while still delivering savings elsewhere. Options range from modifying the disputed SNAP provision to removing it entirely or risking a procedural vote requiring 60 votes—an unlikely scenario in the current Senate. Impact on SNAP Recipients The plan would have expanded work requirements to older adults (up to age 65), a component that remains in the bill for now. Democrats and anti-hunger advocates warned of significant harm to those in need, with more than 3 million individuals projected to lose food stamp access based on Congressional Budget Office estimates. Additional Rulings Expected The Senate parliamentarian is also expected to rule on other elements in the bill, including limits on immigrant eligibility for nutrition aid and changes to federal agencies, with further decisions likely to shape the final legislation. Minnesota Senator Amy Klobuchar, the top Democrat on the Senate Agriculture, Nutrition and Forestry Committee, said: "We will keep fighting to protect families in need," opposing shifts in SNAP costs to states, which she said would result in significant benefit cuts. Arkansas Senator John Boozman, chair of the Senate Agriculture Committee, said Republicans are "exploring options" to comply with Senate rules, while supporting those reliant on SNAP. Senate Republicans are expected to revise the bill to comply with the parliamentarian's rulings or drop the contested SNAP provisions. Further decisions from the adviser on other elements of the megabill are anticipated before any final Senate vote. This article contains reporting from The Associated Press. Related Articles When Are July 2025 SNAP Payments Coming?Republicans Out Of Step With Voters On Medicaid FundingNew York State Facing Lawsuit Over SNAP BenefitsSNAP Recipients Get Extra Money This Month in California 2025 NEWSWEEK DIGITAL LLC.
